392 related articles for article (PubMed ID: 31082822)
21. Chinese Expert Consensus on the Use of Biologics in Patients with Chronic Rhinosinusitis (2022, Zhuhai).
Hong HY; Chen TY; Yang QT; Sun YQ; Chen FH; Lou HF; Wang HT; Yu RL; An YF; Liu F; Wang TS; Lu MP; Qiu QH; Wang XD; Chen JJ; Meng CD; Xie ZH; Meng J; Zeng M; Xu CL; Wang Y; Yang YC; Zhang WT; Tang J; Yang YL; Xu R; Yu GD; Shi ZH; Wei X; Ye HP; Sun YN; Yu SQ; Zhang TH; Yong J; Hang W; Xu YT; Xu Y; Tan GL; Sun N; Yang G; Li YJ; Ye J; Zuo KJ; Zhang LQ; Wang XY; Yang AN; Xu YX; Liao W; Fan YP; Li HB
ORL J Otorhinolaryngol Relat Spec; 2023; 85(3):128-140. PubMed ID: 37019094
[TBL] [Abstract][Full Text] [Related]
22. The Role of Biologics in Chronic Rhinosinusitis with Nasal Polyps.
Bachert C; Desrosiers MY; Hellings PW; Laidlaw TM
J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1099-1106. PubMed ID: 33227522
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design.
De Prado Gomez PharmD MSc L; Khan Mbbs Mph AH; Peters Md AT; Bachert Md PhD C; Wagenmann Md M; Heffler Md PhD E; Hopkins BMBCh C; Hellings Md PhD PW; Zhang PhD M; Xing PhD J; Rowe Md P; Jacob-Nara Md Mph DHSc JA
Am J Rhinol Allergy; 2022 Nov; 36(6):788-795. PubMed ID: 35837739
[TBL] [Abstract][Full Text] [Related]
24. Guidance for contemporary use of biologics in management of chronic rhinosinusitis with nasal polyps: discussion from a National Institutes of Health-sponsored workshop.
Roland LT; Smith TL; Schlosser RJ; Soler ZM; Peters AT; Laidlaw TM; Bleier BS; Ramakrishnan V; Toskala E; Kennedy DW; Luong AU
Int Forum Allergy Rhinol; 2020 Sep; 10(9):1037-1042. PubMed ID: 32484603
[TBL] [Abstract][Full Text] [Related]
25. Innovative treatments for severe uncontrolled chronic rhinosinusitis with nasal polyps.
Huang Y; Zhang N; Bachert C
Expert Rev Clin Immunol; 2023; 19(8):837-845. PubMed ID: 37083285
[TBL] [Abstract][Full Text] [Related]
26. Study protocol: the biologics in severe chronic rhinosinusitis with nasal polyps survey.
Favier V; Daveau C; Carsuzaa F; Fieux M; Vandersteen C; Castillo L; Papon JF; de Gabory L; Saroul N; Verillaud B; Rumeau C; Jankowski R; Michel J; de Bonnecaze G; Lecanu JB; Coste A; Béquignon E; Malard O; Mortuaire G
BMJ Open; 2024 May; 14(5):e083112. PubMed ID: 38749694
[TBL] [Abstract][Full Text] [Related]
27. Targetable pathogenic mechanisms in nasal polyposis.
Schneider AL; Schleimer RP; Tan BK
Int Forum Allergy Rhinol; 2021 Aug; 11(8):1220-1234. PubMed ID: 33660425
[TBL] [Abstract][Full Text] [Related]
28. New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis.
Striz I; Golebski K; Strizova Z; Loukides S; Bakakos P; Hanania NA; Jesenak M; Diamant Z
Clin Sci (Lond); 2023 May; 137(9):727-753. PubMed ID: 37199256
[TBL] [Abstract][Full Text] [Related]
29. Is generative pre-trained transformer artificial intelligence (Chat-GPT) a reliable tool for guidelines synthesis? A preliminary evaluation for biologic CRSwNP therapy.
Maniaci A; Saibene AM; Calvo-Henriquez C; Vaira L; Radulesco T; Michel J; Chiesa-Estomba C; Sowerby L; Lobo Duro D; Mayo-Yanez M; Maza-Solano J; Lechien JR; La Mantia I; Cocuzza S
Eur Arch Otorhinolaryngol; 2024 Apr; 281(4):2167-2173. PubMed ID: 38329526
[TBL] [Abstract][Full Text] [Related]
30. [Decision-making in the treatment of chronic rhinosinusitis with nasal polyps in the era of biologics].
Hoffmann AS; Betz CS; Böscke R; Weber RK
HNO; 2024 Apr; 72(4):225-230. PubMed ID: 38376799
[TBL] [Abstract][Full Text] [Related]
31. [Does aspirin therapy after desensitization still have a role in treatment of chronic rhinosinusitis with nasal polyposis in the era of biologics?].
Klimek F; Förster-Ruhrmann U; Hagemann J; Cuevas M; Gröger M; Klimek L
HNO; 2024 Jul; 72(7):484-493. PubMed ID: 38409556
[TBL] [Abstract][Full Text] [Related]
32. Emerging biologics for the treatment of chronic rhinosinusitis.
Pauwels B; Jonstam K; Bachert C
Expert Rev Clin Immunol; 2015 Mar; 11(3):349-61. PubMed ID: 25651905
[TBL] [Abstract][Full Text] [Related]
33. Increased serum amyloid A in nasal polyps is associated with systemic corticosteroid insensitivity in patients with chronic rhinosinusitis with nasal polyps: a pilot study.
Lu H; Lin XS; Yao DM; Zhuang YY; Wen GF; Shi J; Sun YQ
Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):401-408. PubMed ID: 29177948
[TBL] [Abstract][Full Text] [Related]
34. Chronic Rhinosinusitis With Nasal Polyps: Quality of Life in the Biologics Era.
Mullol J; Azar A; Buchheit KM; Hopkins C; Bernstein JA
J Allergy Clin Immunol Pract; 2022 Jun; 10(6):1434-1453.e9. PubMed ID: 35306180
[TBL] [Abstract][Full Text] [Related]
35. Clinical and biological markers in disease and biologics to treat chronic rhinosinusitis.
Guo CL; Wang CS; Liu Z
Curr Opin Allergy Clin Immunol; 2022 Feb; 22(1):16-23. PubMed ID: 34789677
[TBL] [Abstract][Full Text] [Related]
36. Mepolizumab in chronic rhinosinusitis with nasal polyposis.
Liu X; Charn TC; Wang DY
Immunotherapy; 2023 Oct; 15(14):1105-1116. PubMed ID: 37435679
[TBL] [Abstract][Full Text] [Related]
37. Chronic Rhinosinusitis with Nasal Polyps: Targeting IgE with Anti-IgE Omalizumab Therapy.
Kariyawasam HH; James LK
Drug Des Devel Ther; 2020; 14():5483-5494. PubMed ID: 33328726
[TBL] [Abstract][Full Text] [Related]
38. The role of omalizumab in the treatment of chronic rhinosinusitis with nasal polyposis.
Aldinger JP; Dobyns T; Lam K; Han JK
Expert Opin Biol Ther; 2021 Sep; 21(9):1143-1149. PubMed ID: 34334061
[No Abstract] [Full Text] [Related]
39. Nasal polyposis: an inflammatory condition requiring effective anti-inflammatory treatment.
Chin D; Harvey RJ
Curr Opin Otolaryngol Head Neck Surg; 2013 Feb; 21(1):23-30. PubMed ID: 23172039
[TBL] [Abstract][Full Text] [Related]
40. Biologics for chronic rhinosinusitis with nasal polyps.
Bachert C; Zhang N; Cavaliere C; Weiping W; Gevaert E; Krysko O
J Allergy Clin Immunol; 2020 Mar; 145(3):725-739. PubMed ID: 32145872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
